Investor profile
IP Group plc
See how your deck fits this investor's thesis, stage, and ticket size.
Analyse your fitInvestment thesis
IP Group is one of the world's most active investors in university and other research-based companies, with a proven track record of backing and nurturing science and technology-based businesses to deliver a better future for people and planet. The firm focuses on the commercialisation of intellectual property originating from universities and research institutions, particularly in the areas of HealthTech, DeepTech and CleanTech. Unlike traditional time-limited VC funds, IP Group invests from its permanent balance sheet, enabling it to co-found companies, follow its money through subsequent funding rounds, and support portfolio companies from inception through to growth and exit without artificial timescale pressures. Through its wholly-owned subsidiary Parkwalk — the UK's largest growth EIS fund manager — and managed mandates (including for Hostplus), IP Group provides a flexible, multi-stage capital approach across the full lifecycle of science-based businesses, underpinned by deep partnerships with leading universities including Oxford, Cambridge, Bristol, Imperial College London, and Australia's Group of Eight.
Notable quotes
“As one of the world's most experienced university IP investors, our unique model – combining deep partnerships with leading research institutions and access to long-term committed capital – positions us to support breakthrough science from inception to scale.”
“We have an excellent team that combines university relationships with deep sector experience and networks, allowing us to access highly differentiated dealflow.”
“Having supported AccelerComm since inception, we're delighted to see the company attract an experienced CEO and close a new funding round, supported by additional blue-chip investors.”
Recent investments
| Company | Round | Size | Date |
|---|---|---|---|
| Oxford Nanopore Technologies | Equity Issue / Follow-on | $101m | 2024-08-01 |
| Artios Pharma | Series C | $115m | 2025-11-01 |
| Oxa Autonomy | Series D | $103m | 2026-03-04 |
| First Light Fusion | Series C (first close) | $32m | 2026-04-21 |
| AccelerComm | Series B | $15m | 2025-06-01 |
| OXCCU | Series A | $26m | 2025-09-01 |
| Lumai | Seed/Series A | $10m | 2025-01-01 |
| Featurespace | Acquisition (by Visa) | — | 2024-12-19 |
| Hinge Health | IPO (NYSE) | $258m | 2025-05-01 |
| Istesso | Follow-on | — | 2023-01-01 |
Frequent co-investors
| VC firm | Deals together |
|---|---|
| Parkwalk Advisors | 30 |
| Hostplus | 12 |
| Novo Holdings | 6 |
| Northern Gritstone | 5 |
| Sofinnova Partners | 4 |
| NVentures (NVIDIA) | 3 |
Fit check
Is IP Group plc a match for your startup?
Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.
Analyse your fit